Abemaciclib Delays Start of Subsequent Chemotherapy

CDK 4/6 benefit extends into subsequent therapy.

Key Protein in HER2+ Breast Cancer Found to Lead to Metastasis

A new study has found that this protein may be responsible for lower survival rates in patients with HER2+ breast cancer.

Despite Recommendations, Chemo Use in Early Stage Breast Cancer Drops

The evidence for chemo hasn't changed. Practice has.

Local Ablation Dramatically Boosts Survival in Renal Cell Carcinoma

When surgery isn't an option, what's the best second choice for RCC?

Major Breakthrough: New Class of Anti-Cancer Drug Effective Against Kidney Cancer

Can a new agent block tumor growth in kidney cancer?

Algorithm Predicts Which High-Risk Lesions Will Upgrade to Cancer, Reducing Unnecessary Surgeries

A new algorithm could significantly eliminate unnecessary operations for breast cancer lesions by predicting which ones will become cancerous.  

Women With Schizophrenia are at Higher Risk for Breast Cancer

Schizophrenia and the incidence of breast cancer may be linked together.

Phase II Study Results Find Rituximab & Chemotherapy Combination Treatment Prolongs Survival in Patients With PCNSL

A new study finds that this standard combo therapy is safer and more beneficial than the latest pharmaceutical agents.

Lymphoma Survivors Report Burdensome Late Effects & Follow-Up Care After Multimodality Treatment

Patients with HL and NHL report physical burdens and "suboptimal" delivery of survivorship information and follow-up care.

Is Hydroxyurea Too Risky to be a First Line Therapy in PV?

Does the standard first-line treatment for PV increase risk of leukemia?

Breast Implants Linked to Increased Risk of Developing Breast ALCL

A new study found that breast implants are linked to an increased risk of this rare type of cancer.

Night Shifts Found to Increase Risk for Multiple Cancers in Female Nurses

A new international study found that night shift work significantly increases the risk of developing common cancers in women.

FDA Approves TRISENOX Injection for First Line Treatment of Acute Promyelocytic Leukemia

The U.S. Food and Drug Administration has approved the use of the intravenous drug TRISENOX (Teva Pharmaceutical Industries Ltd.) in combination with tretinoin for first line treatment of adult patients who have been newly-diagnosed with low-risk APL.

FDA Approves GammaPod for Breast Cancer Treatment

The U.S. Food and Drug Administration has approved a new breast cancer treatment machine that uses gamma rays to target tumors without harming healthy tissue.

NCCN Updates Clinical Practice Guidelines for Hodgkin Lymphoma

The National Comprehensive Cancer Network has issued updated guidelines for Hodgkin lymphoma, which focus on the management of HL using existing treatments and the need for long-term follow-up after treatment completion.

© 2024 /alert® unless otherwise noted. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
Privacy Policy | Terms of Use | Editorial Policy | Advertising Policy